PDF
AMMI Canada Guideline | Open Access
Guidance for Practitioners on the Use of Antiviral Drugs to Control Influenza Outbreaks in Long-Term Care Facilities in Canada, 2014-2015 Season
Fred Y Aoki
,1 Upton D Allen,2 H Grant Stiver,3 Michel Laverdière,4 Danuta Skowronski,5 and Gerald A Evans61Professor of Medicine, Medical Microbiology and Pharmacology & Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
2Professor, Department of Pediatrics & Institute of Health Policy, Management and Evaluation; Senior Associate Scientist, Research Institute; Chief, Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
3Professor Emeritus of Medicine, Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
4Department of Microbiology-Infectious Disease, Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada
5Epidemiology Lead, Influenza & Emerging Respiratory Pathogens, BC Centre for Disease Control, Vancouver, British Columbia, Canada
6Professor of Medicine, Biomedical & Molecular Sciences and Pathology & Molecular Medicine; Chair, Division of Infectious Diseases, Department of Medicine, Kingston General Hospital, Queen’s University, Kingston, Ontario, Canada
Abstract
This article has no abstract.
Copyright
Copyright © 2015 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
